NasdaqGS:REGNBiotechs
Is Regeneron Pharmaceuticals (REGN) Offering Value After Recent Share Price Gains?
This article examines whether Regeneron Pharmaceuticals, at around US$787.50, is offering good value right now and walks through what the current price could mean for long term investors.
The stock has returned 0.4% over the past week, 4.3% over the past month, 1.4% year to date, 15.2% over 1 year, 6.4% over 3 years and 69.4% over 5 years. These figures provide useful context for thinking about what you are paying today.
Recent headlines around Regeneron have focused on its position in the...